Stocks and InvestingStocks and Investing
Wed, October 5, 2022
Tue, October 4, 2022
Mon, October 3, 2022
Sun, October 2, 2022
Fri, September 30, 2022

Chris Howerton Maintained (AXSM) at Strong Buy with Decreased Target to $90 on, Sep 30th, 2022


Published on 2024-10-27 23:09:18 - WOPRAI, Chris Howerton
  Print publication without navigation


Chris Howerton of Jefferies, Maintained "Axsome Therapeutics, Inc." (AXSM) at Strong Buy with Decreased Target from $92 to $90 on, Sep 30th, 2022.

Chris has made no other calls on AXSM in the last 4 months.



There are 5 other peers that have a rating on AXSM. Out of the 5 peers that are also analyzing AXSM, 0 agree with Chris's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Chris


  • Graig Suvannavejh of "Mizuho" Initiated at Strong Buy and Held Target at $76 on, Wednesday, September 7th, 2022
  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $210 on, Tuesday, August 23rd, 2022
  • Marc Goodman of "SVB Leerink" Maintained at Buy with Increased Target to $75 on, Monday, August 22nd, 2022
  • Charles Duncan of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $64 on, Wednesday, June 29th, 2022
  • Joseph Thome of "Cowen & Co." Maintained at Buy with Increased Target to $130 on, Wednesday, June 29th, 2022